CD44 and cancer: Furthermore, a treatment of TME-HCT-116 cells with 5-FU, resveratrol or both agents in combination, significantly down-regulated inflammation (p-NF-kB), vascularisation (VEGF) and cancer stem cell (CD44, CD133, ALDH1) expression.